Market closed · data as of 27 Aug 2026 · source NSE via Alphave. Open the live chart →
Sudeep Pharma is a Gujarat-based manufacturer of specialty ingredients and pharmaceutical excipients, known for mineral-based products such as calcium, iron and zinc salts supplied to pharmaceutical, nutrition and food customers in India and abroad. It listed on the exchanges in late 2025.
Sudeep Pharma Ltd. is a constituent of NIFTY MICROCAP 250. See where it sits on the market heatmap →
Consolidated annual figures taken from Sudeep Pharma Ltd.'s own filed statements — not estimates, and not restated by us. The most recent period shown is FY26 (year ended 31 Mar 2026).
| Metric | FY26 |
|---|---|
| EPS (basic, ₹) | 15.50 |
| Book value / share (₹) | 79.51 |
| Return on equity | 19.3% |
| Return on capital employed | 21.3% |
| Operating margin | 32.2% |
| Net margin | 27.1% |
| EBITDA | ₹222 Cr |
| Free cash flow | ₹-49 Cr |
| Total debt | ₹148 Cr |
| Debt to equity | 0.17 |
| Interest coverage | 27.2 |
| Current ratio | 3.09 |
| Shares outstanding | 11,29,49,000 |
Open the full income statement, balance sheet and cash flow for SUDEEPPHRM →
As disclosed for the quarter ended 30 Jun 2026.
Institutional ownership changes quarter to quarter. See daily FII and DII flows across the market →
Companies Alphave classifies in the same sub-sector, closest by market capitalisation.